Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
Skip to main content
Donate

Let's beat cancer sooner

Tackling brain tumours, understanding immunotherapy and revealing cancer’s genetics at the end of life – accelerating progress at our Centres

Category: Science blog May 13, 2016

We’ve announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor.

Read More

More pieces of the jigsaw fall into place at the 2016 AACR Conference

Category: Science blog May 6, 2016

We look back on the key topics and trends discussed at the American Association of Cancer Research’s recent Annual Meeting in New Orleans

Read More

Gene editing technology could help engineer better cancer targeting immune cells

Category: Science blog April 15, 2016

We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.

Read More

Virtual reality and precision diagnosis among shortlist for our Grand Challenge

Category: Science blog April 14, 2016

This entry is part 10 of 10 in the series Grand Challenge

Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment.

Read More

Microbubbles, a cancer cell shape sorter, and artificial intelligence – our latest innovative science projects

Category: Science blog April 4, 2016

We take a look at five exciting projects that have just been funded by our Pioneer Award.

Read More

Blood analysis could offer a real-time ‘snapshot’ of melanoma treatment

Category: Science blog March 15, 2016

We explore the latest research from our scientists in Manchester that’s tracking how melanomas respond to treatment by analysing patient blood samples.

Read More

Blocking the escape routes: how an HIV drug exposes skin cancer’s weaknesses

Category: Science blog March 14, 2016

A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a ‘targeted’ cancer drug.

Read More